ATR

AptarGroup Inc. Common Stock
Healthcare · Medical Instruments & Supplies · NYSE · United States
$125.45+1.66%
Market cap $7.8BNext earnings 2026-10-29Updated Sep 22, 2026
FAIR VALUE · CONSENSUS
$125.45+0.0%
confidence-weighted across 5 of 6 models
Now $125.45
$125.45
$59.76$129.42
TrimBronze46
Price vs fair value
23.5% above
-19.0% to fair value
ACCE score
51
out of 100
Analysts
71% buy
7 covering
P/E
22.3x
forward 19.7x
1-year return
-5.5%
Dividend yield
1.52%
Unlock the ACCE read
INVESTOR

Overview

Reports in 35 days, last quarter beat by 0.1%.

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Price

-5.0% · 1Y

Valuation

INVESTOR
Full valuation engine INVESTOR FEATURE

Six independent models converge on one confidence-weighted fair value, with full methodology and editable assumptions.

  • +All six models: DCF, P/E and EV/EBITDA comps, Graham, dividend discount, residual income
  • +Scenario bands, sensitivity tornado, and the 5-year historical valuation range
  • +Editable DCF workbench with saved scenarios

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: conviction breakdown, earnings quality, score history, and backtested returns.

  • +Conviction score breakdown and earnings-quality grade
  • +Growth / value / quality / momentum component scores
  • +90-day score history and score-threshold backtests

Analysts

Wall Street consensus

Bullish71% buy · 7 covering analysts
● Strong buy 4● Buy 1● Hold 2● Sell 0● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO
Smart money tracking PRO FEATURE

Follow the institutions: 13F position changes, insider trades, and active 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Recent open-market insider transactions
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

This stock Peer Peer median weaker → stronger
P/Ebetter than 33% of peers
low 0.0x22.3xhigh 247.5x
ROEbetter than 100% of peers
low -10%13%high 13%
Div yieldbetter than 100% of peers
low 0.0%1.5%high 1.5%

Algorithmic peers (6)

TickerCompanyMcapP/EROED/EYieldQuality
RGENRepligen Corporation Common Stock$10.2B247.52.0%0.270.0%-Compare
AVTRAvantor Inc. Common Stock$10.2B--9.7%0.710.0%-Compare
BLCOBausch + Lomb Corporation Common Shares$6.0B--2.5%0.790.0%-Compare
COOThe Cooper Companies Inc. Common Stock$10.3B18.66.8%0.300.0%-Compare
MMEDMiniMed Group Inc. Common Stock$5.9B--8.7%0.040.0%-Compare
ALGNAlign Technology Inc. Common Stock$10.4B25.510.2%0.010.0%-Compare

Sector report card

Where ATR ranks against its sector peers on each metric.

Computing percentiles…

News and Record

Reports in 35 days, last quarter beat by 0.1%.

Press releases mentioning this company

Ask anything, Pro feature

Ask questions about this stock in plain language. Answered from company fundamentals + recent valuations.

PRO

Recent performance

1 week
+0.6%
1 month
-6.9%
3 months
+0.9%
6 months
+0.6%
YTD
+2.9%
1 year
-5.5%

SEC filings

40 filings
September 2026
Sep 21
8-KCurrent reportPeriod 2026-09-21
Sep 10
8-KCurrent reportPeriod 2026-09-04
Sep 3
Form 4Insider transactionPeriod 2026-09-02
37 more filings + AI summaries on Investor+.INVESTOR